Company Overview and News
The ASX 200 has finished firmer for the ninth time in the past 10 sessions today. The index was boosted by a rally in the energy sector following a surge in oil prices overnight to 3.5 year highs.
Caltex Australia chairman Steven Gregg says the nation has never had a more flexible fuel supply arrangement despite recent concerns about how well oil reserves would hold up in a crisis.
KWM Director Nominees S. Shariq Yosufzai and Sushil ("Sam") Kapoor Are Appointed to Aqua Metals Board
-Believes It is Critical for Aqua Metals to Immediately Retain a Credible and Qualified Interim CEO and Strongly Recommends Former Chief Commercial Officer Steve Cotton for This Role -Highlights Serious Concerns about the Company's Significant Underperformance and Poor Corporate Governance Practices -Reiterates Desire to Work Constructively with Aqua Metals to Reconstitute the Board, But Beliefs Substantial Change is Required to Reverse the Recent, Drastic Underperformance and Fix the Company's Governance
Believes Yosufzai Is Uniquely Qualified to Serve As Board Chairman Given His Relevant Industry Experience and Proven Track Record of Leadership and Business Growth; Comments on Aqua Metals' Recently Announced Plans for a New CEO Search and Board Refreshment; Cautions the Board Against Proceeding with a CEO Replacement or any Material Transactions Until After Shareholders Have Had the Opportunity to Elect a New Board at the Upcoming Annual Meeting
BRANDS come and brands go. It’s the way of things in the ever changing commercial world.
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) steadily trended downward into the close from its intra-day high at 12.49pm of 6,083 points.
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) has remained elevated throughout the morning session, only three points below the day's high of 6,079.4.
Wall Street got off to a strong start on the first trading day of the week, with major stock indexes rising more than 1 percent as U.S. bond yields slipped ahead of Asia's Tuesday trading day.
S&P/ASX 200 will look to continue its positive run with ASX 200 futures trading higher, signalling early gains for the ASX 200.
Fuel retailer Caltex Australia's full-year profit has risen just one per cent to $619 million annual.
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) is looking to continue its positive run with ASX 200 futures trading higher, signally early gains for the ASX 200.
The purchase by Caltex Australia of a stake in a fuel company in the Philippines could be good news for Kiwi motorists, says the AA.
MANILA, Philippines — Independent oil player Seaoil Philippines Inc. has taken in Caltex Australia Petroleum Pty Ltd. as long-term strategic partner for its expansion program.
CALTEX AUSTRALIA Petroleum Pty Ltd. is acquiring a 20% equity interest in Seaoil Philippines, Inc. in a deal that the local company said is intended to be a long-term partnership between the two independent oil players.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...